Business
Why the Orthocell (ASX:OCC) share price is edging higher today
The Orthocell Ltd (ASX: OCC) share price is edging higher today. This comes after the company announced it has completed an important step to obtaining its commercial licence in Australia for its CelGro medical device.
During market open, the Orthocell share price reached as high as 43.5 cents. However, at the time of writing, the company’s shares have slightly retreated to 42.5 cents, up 1.2%.
Quick take on Orthocell
Orthocell focuses on the development and commercialisation of novel collagen medical devices and cellular therapies.
Its lead product, CelGro, facilitates tissue repair and healing in a variety of orthopaedic, reconstructive and surgical applications. This includes treating defects in areas of the body such as…
-
General17 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News24 hours agoYork family honours late son with tractor museum to fund cancer research
-
General23 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Noosa News19 hours agoPerth Royal Show attendance slumps to 10-year low